Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.

<h4>Purpose</h4> <p>We have identified human medicinal products for which animal data were used as evidence for withdrawal, determined whether the adverse reactions were reported in humans, established whether confirmatory human studies were conducted, and explored the withdrawal...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Onakpoya, I, Heneghan, C, Aronson, J
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	Wiley 2017

Ижил төстэй зүйлс

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
-н: Onakpoya, I, зэрэг
Хэвлэсэн: (2016)

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
-н: Onakpoya, I, зэрэг
Хэвлэсэн: (2016)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
-н: Onakpoya, IJ, зэрэг
Хэвлэсэн: (2016)

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
-н: Onakpoya, I, зэрэг
Хэвлэсэн: (2017)

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
-н: Igho J. Onakpoya, зэрэг
Хэвлэсэн: (2019-03-01)

An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
-н: Onakpoya, I
Хэвлэсэн: (2017)

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.
-н: Onakpoya, I, зэрэг
Хэвлэсэн: (2017)

The Adverse Drug Reactions Registered During the Postmarketing Period
-н: E. V. Shubnikova, зэрэг
Хэвлэсэн: (2019-03-01)

Rotavirus Vaccine Withdrawal in the United States: The Role of Postmarketing Surveillance
-н: Gilles Delage
Хэвлэсэн: (2000-01-01)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
-н: Onakpoya, I, зэрэг
Хэвлэсэн: (2018)

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
-н: Colleen M. Kingsbury, зэрэг
Хэвлэсэн: (2024-09-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
-н: Wei Mao, зэрэг
Хэвлэсэн: (2025-01-01)

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
-н: Daniele Sartori, зэрэг
Хэвлэсэн: (2020-08-01)

Postmarket sequential database surveillance of medical products
-н: Maro, Judith C
Хэвлэсэн: (2013)

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
-н: Yamin Shu, зэрэг
Хэвлэсэн: (2023-05-01)

Postmarket Surveillance of Neuroendovascular Devices
-н: Marie K. Luff, зэрэг
Хэвлэсэн: (2024-03-01)

Postmarket Drug Surveillance Without Trial Costs: Discovery of Adverse Drug Reactions Through Large-Scale Analysis of Web Search Queries
-н: Yom-Tov, Elad, зэрэг
Хэвлэсэн: (2013-06-01)

Redefining rapid reviews: a flexible framework for restricted systematic reviews
-н: Plüddemann, A, зэрэг
Хэвлэсэн: (2018)

Safety of oral nemonoxacin: A systematic review of clinical trials and postmarketing surveillance
-н: Jinyi Yuan, зэрэг
Хэвлэсэн: (2022-12-01)

Postmarketing pharmacovigilance: Remdesivir and cardiovascular events
-н: John T. Sullivan
Хэвлэсэн: (2022-04-01)

Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
-н: Onakpoya, IJ, зэрэг
Хэвлэсэн: (2020)

Use of real-world evidence in postmarketing medicines regulation in the European Union: a systematic assessment of European Medicines Agency referrals 2013–2017
-н: Kevin Wing, зэрэг
Хэвлэсэн: (2019-10-01)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
-н: Aronson, J
Хэвлэсэн: (2008)

An agenda for research on adverse drug reactions.
-н: Aronson, J
Хэвлэсэн: (2007)

Adverse drug reactions--no farewell to harms.
-н: Aronson, J
Хэвлэсэн: (2007)

Pharmacogenetics and adverse drug reactions
-н: Ferner, R, зэрэг
Хэвлэсэн: (2010)

Clinical efficacy and safety of alemtuzumab in postmarketing practice
-н: N. V. Khachanova
Хэвлэсэн: (2019-06-01)

Comparison of Data Mining Methods for the Signal Detection of Adverse Drug Events with a Hierarchical Structure in Postmarketing Surveillance
-н: Goeun Park, зэрэг
Хэвлэсэн: (2020-08-01)

Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia Region, 2014–19
-н: Pasquale Stefanizzi, зэрэг
Хэвлэсэн: (2022-01-01)

Postmarketing Surveillance: Review of Open Sources of Drug Safety Data
-н: E. V. Shubnikova
Хэвлэсэн: (2024-10-01)

Serum trough level as a postmarketing quality measure of generic vancomycin products
-н: Ya-Wen Tsai, зэрэг
Хэвлэсэн: (2020-04-01)

The need for randomization in animal trials: an overview of systematic reviews
-н: Hirst, J, зэрэг
Хэвлэсэн: (2014)

Orphan Therapies: Making Best Use of Postmarket Data
-н: Li, Lingling, зэрэг
Хэвлэсэн: (2016)

Postmarketing safety evaluation of belimumab: a pharmacovigilance analysis
-н: Huqun Li, зэрэг
Хэвлэсэн: (2025-01-01)

Pharmacoepidemiology – Assessing the Risks and Benefits of Drugs in the Postmarketing Phase
-н: Christoph R. Meier
Хэвлэсэн: (2006-02-01)

Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: A systematic review and meta-analysis of randomised clinical trials.
-н: Onakpoya, I, зэрэг
Хэвлэсэн: (2014)

Adverse drug reactions: definitions, diagnosis, and management.
-н: Edwards, I, зэрэг
Хэвлэсэн: (2000)

Reduced salt intake for heart failure: A systematic review
-н: Mahtani, K, зэрэг
Хэвлэсэн: (2018)

Postmarketing assessment of a switchable similar anastrozole product in Brazilian breast cancer patients
-н: Manuela Vasquez Cardoso, зэрэг
Хэвлэсэн: (2023-04-01)

Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.
-н: Loke, Y, зэрэг
Хэвлэсэн: (2006)